Electroconvulsive therapy and Parkinson

Effect of electroconvulsive therapy on motor and psychiatric symptoms of drug-resistant Parkinson's patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N95

Enrollment

Registered

2018-06-15

Start date

2016-06-19

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson. Parkinson's disease

Interventions

The intervention group in addition to dopaminergic medications, will receive a 25-julestwo-sided frontotemporal ectoplasmic twice a week.If the person does not get seizure, the next stimulus is perfor

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Parkinson's patients with motor and psychiatric symptoms resistant to drug therapy Age between 40 and 75 years

Exclusion criteria

Exclusion criteria: Cardiovascular patients; Patients with cognitive impairment; Patients with the history of seizure, stroke

Design outcomes

Primary

Measure	Time frame
Motor symptoms. Timepoint: At the beginning of the study, the end of the sixth week and one month after the end of the study. Method of measurement: Using the Unified Parkinson's disease rating scale (UPDRS).;Psychiatric symptoms. Timepoint: At the beginning of the study, the end of the sixth week and one month after the end of the study. Method of measurement: Using the Brief Psychiatric Rating Scale (BPRS).	—

Measure

Time frame

Motor symptoms. Timepoint: At the beginning of the study, the end of the sixth week and one month after the end of the study. Method of measurement: Using the Unified Parkinson's disease rating scale (UPDRS).;Psychiatric symptoms. Timepoint: At the beginning of the study, the end of the sixth week and one month after the end of the study. Method of measurement: Using the Brief Psychiatric Rating Scale (BPRS).

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJaza Rahkan

Kermanshah University of Medical Sciences

pjsrahkan@yahoo.com+98 83 3826 1046

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026